- Home
- USEA vs OSRH Comparison
USEA vs OSRH Comparison
Compare USEA & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEA | OSRH |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 17.9M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | USEA | OSRH |
|---|---|---|
| Price | $2.76 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.3K | ★ 27.5M |
| Earning Date | 05-21-2026 | 05-19-2026 |
| Dividend Yield | ★ 11.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,905,805.00 |
| Revenue This Year | $5.55 | $9.30 |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $0.08 |
| 52 Week High | $2.91 | $0.91 |
Technical Indicators
Market Signals| Indicator | USEA | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 33.28 |
| Support Level | $2.65 | N/A |
| Resistance Level | $2.78 | $0.53 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 55.65 | 4.38 |
Price Performance
Historical ComparisonAbout USEA United Maritime Corporation
United Maritime Corp is an international shipping company currently specializing in world-wide seaborne transportation services. It currently operates a fleet of dry bulk vessels, comprising Panamax, Capesize and Kamsarmax vessels. Its vessels include Dukeship, Nisea, Cretansea, Chrisea, Synthesea, and Exelixsea.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.